Loading resource…

American Diabetes Association
Published by the American Diabetes Association, this supplement outlines comprehensive guidance for type 1 and type 2 diabetes, including glycemic targets, hypoglycemia prevention, and use of SGLT2 inhibitors. It includes specific sections on liver disease associated with diabetes, such as MASLD/MASH, and recommendations for screening and treatment. The document also addresses glucagon administration, diabetic ketoacidosis management, and strategies for patient education and monitoring. It is intended for health professionals caring for patients with diabetes across the care continuum.
No account needed